II
CPRX

Inspire Investing’s Catalyst Pharmaceutical CPRX Stock Holding History

Inspire Investing’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-53,157
Closed -$1.24M – 1119
2025
Q4 		$1.24M Buy
+53,157
New +$1.18M 0.11% 220
2025
Q3 		– Sell
-37,564
Closed -$815K – 866
2025
Q2 		$815K Buy
37,564
+3,753
+11% +$88.6K 0.09% 239
2025
Q1 		$820K Sell
33,811
-4,599
-12% -$104K 0.1% 195
2024
Q4 		$802K Sell
38,410
-1,981
-5% -$42.6K 0.09% 272
2024
Q3 		$803K Buy
+40,391
New +$749K 0.08% 273

Other funds holding CPRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Inspire Investing's CPRX Position: Q1 2026 in Review

Inspire Investing sold out of Catalyst Pharmaceutical (CPRX) in Q1 2026, closing a stake of 53,157 shares — an estimated $1.24M sold.

Inspire Investing first reported a position in CPRX in Q3 2024 and held it in 5 quarters. The position peaked at $1.24M in Q4 2025. 380 funds tracked by Wall St. Rank hold CPRX as of Q1 2026.

  • Inspire Investing reported no remaining Catalyst Pharmaceutical position as of Q1 2026 after selling out during the quarter.
  • Inspire Investing sold 53,157 Catalyst Pharmaceutical shares in Q1 2026, an estimated $1.24M.
  • Inspire Investing first reported a position in Catalyst Pharmaceutical in Q3 2024 and held it in 5 quarters.
  • Inspire Investing's Catalyst Pharmaceutical position peaked at $1.24M in Q4 2025.
  • 380 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q1 2026.

Based on Inspire Investing's 13F filing for Q1 2026, filed 23 Apr 2026.